- Home
- VTYX vs BFAC Comparison
VTYX vs BFAC Comparison
Compare VTYX & BFAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- BFAC
- Stock Information
- Founded
- VTYX 2018
- BFAC 2021
- Country
- VTYX United States
- BFAC United States
- Employees
- VTYX N/A
- BFAC N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- BFAC Blank Checks
- Sector
- VTYX Health Care
- BFAC Finance
- Exchange
- VTYX Nasdaq
- BFAC Nasdaq
- Market Cap
- VTYX 148.4M
- BFAC 152.7M
- IPO Year
- VTYX 2021
- BFAC 2021
- Fundamental
- Price
- VTYX $1.73
- BFAC $11.10
- Analyst Decision
- VTYX Buy
- BFAC
- Analyst Count
- VTYX 5
- BFAC 0
- Target Price
- VTYX $8.40
- BFAC N/A
- AVG Volume (30 Days)
- VTYX 1.1M
- BFAC 4.9K
- Earning Date
- VTYX 11-07-2024
- BFAC 01-01-0001
- Dividend Yield
- VTYX N/A
- BFAC N/A
- EPS Growth
- VTYX N/A
- BFAC 140.63
- EPS
- VTYX N/A
- BFAC 0.60
- Revenue
- VTYX N/A
- BFAC N/A
- Revenue This Year
- VTYX N/A
- BFAC N/A
- Revenue Next Year
- VTYX N/A
- BFAC N/A
- P/E Ratio
- VTYX N/A
- BFAC $18.52
- Revenue Growth
- VTYX N/A
- BFAC N/A
- 52 Week Low
- VTYX $1.67
- BFAC $10.78
- 52 Week High
- VTYX $11.48
- BFAC $11.55
- Technical
- Relative Strength Index (RSI)
- VTYX 30.10
- BFAC 45.52
- Support Level
- VTYX $2.10
- BFAC $11.13
- Resistance Level
- VTYX $2.36
- BFAC $11.14
- Average True Range (ATR)
- VTYX 0.12
- BFAC 0.00
- MACD
- VTYX -0.05
- BFAC -0.00
- Stochastic Oscillator
- VTYX 8.76
- BFAC 37.50
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About BFAC Battery Future Acquisition Corp.
Battery Future Acquisition Corp is a blank check company.